Skip to main content
Top
Published in: Surgical Endoscopy 4/2024

21-02-2024 | Gastrectomy

Transthoracic single-port-assisted laparoscopic gastrectomy versus laparoscopic transhiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction: a single-center retrospective study

Authors: Jin Li, Wenjun Xiong, Huahui Ou, Tingting Yang, Shuihua Jiang, Haipeng Huang, Yansheng Zheng, Lijie Luo, Xiaofeng Peng, Wei Wang

Published in: Surgical Endoscopy | Issue 4/2024

Login to get access

Abstract

Background

The surgical approach for patients with Siewert type II AEG remains controversial. Several studies have described a new laparoscopic radical resection approach of Siewert type II AEG through the left diaphragm. However, the technical safety and feasibility of the new surgical approach compared with the transhiatal approach have not yet been tested.

Study design

We retrospectively reviewed patients with AEG who underwent TSLG and LTH operations in the Guangdong Provincial Hospital of Chinese Medicine between January 2017 and April 2021. Histologically confirmed AEG and D2 lymphadenectomy with curative R0 patients were included, and patients with Siewert I/III AEG or distant metastasis were excluded. Blood loss, the amount of harvested lymph node, and complications related to surgery were evaluated.

Results

A total of 99 patients with Siewert type II AEG were analyzed, 44 in the TSLG group and 55 in the LTH group. There was no difference in clinicopathological features between the two groups. The more harvested lymph node (23.33 ± 11.41 vs. 32.18 ± 12.85, p < 0.01), lower mediastinal lymph node (1.07 ± 2.08 vs. 3.25 ± 3.31, p < 0.01), and longer proximal margin length (3.08 ± 1.19 vs. 4.47 ± 0.95 cm, p < 0.01) were observed in the TSLG group. The rate of cure (R0 gastrectomy) in the TSLG group was higher than that in the LTH group (100% vs. 89.09%, p = 0.03).

Conclusion

The TSLG approach is associated with improved surgical views, simplified lymphatic dissection in the inferior mediastinum, and more reliable margins. TSLG surgery may be an effective addition to LTH surgery, particularly when lower mediastinal lymph node metastases are suspected.

Graphical abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Hasegawa S, Yoshikawa T (2010) Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer 13(2):63–73CrossRefPubMed Hasegawa S, Yoshikawa T (2010) Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer 13(2):63–73CrossRefPubMed
2.
go back to reference Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85(11):1457–1459CrossRefPubMed Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85(11):1457–1459CrossRefPubMed
3.
go back to reference Sasako M, Sano T, Yamamoto S et al (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7(8):644–651CrossRefPubMed Sasako M, Sano T, Yamamoto S et al (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7(8):644–651CrossRefPubMed
4.
go back to reference Kurokawa Y, Sasako M, Sano T et al (2015) Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg 102(4):341–348CrossRefPubMed Kurokawa Y, Sasako M, Sano T et al (2015) Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg 102(4):341–348CrossRefPubMed
5.
go back to reference Sugita S, Kinoshita T, Kuwata T et al (2021) Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type II adenocarcinoma of the esophagogastric junction. Surg Endosc 35(1):340–348CrossRefPubMed Sugita S, Kinoshita T, Kuwata T et al (2021) Long-term oncological outcomes of laparoscopic versus open transhiatal resection for patients with Siewert type II adenocarcinoma of the esophagogastric junction. Surg Endosc 35(1):340–348CrossRefPubMed
6.
go back to reference Huang CM, Lv CB, Lin JX et al (2017) Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study. Surg Endosc 31(9):3495–3503CrossRefPubMed Huang CM, Lv CB, Lin JX et al (2017) Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study. Surg Endosc 31(9):3495–3503CrossRefPubMed
7.
go back to reference Sugita S, Kinoshita T, Kaito A, Watanabe M, Sunagawa H (2018) Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction. Surg Endosc 32(1):383–390CrossRefPubMed Sugita S, Kinoshita T, Kaito A, Watanabe M, Sunagawa H (2018) Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction. Surg Endosc 32(1):383–390CrossRefPubMed
8.
go back to reference Luo S, Xu J, Xiong W et al (2021) Feasibility and efficacy of transthoracic single-port assisted laparoscopic esophagogastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction. Ann Transl Med 9(20):1540CrossRefPubMedPubMedCentral Luo S, Xu J, Xiong W et al (2021) Feasibility and efficacy of transthoracic single-port assisted laparoscopic esophagogastrectomy for Siewert type II adenocarcinoma of the esophagogastric junction. Ann Transl Med 9(20):1540CrossRefPubMedPubMedCentral
9.
go back to reference Luo SJ, Xiong WW, Chen Y et al (2021) Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type II adenocarcinoma of the esophagogastric junction. Zhonghua Wei Chang Wai Ke Za Zhi 24(8):684–690PubMed Luo SJ, Xiong WW, Chen Y et al (2021) Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type II adenocarcinoma of the esophagogastric junction. Zhonghua Wei Chang Wai Ke Za Zhi 24(8):684–690PubMed
10.
go back to reference Pang W, Liu G, Zhang Y et al (2021) Total laparoscopic transabdominal-transdiaphragmatic approach for treating Siewert II tumors: a prospective analysis of a case series. World J Surg Oncol 19(1):26CrossRefPubMedPubMedCentral Pang W, Liu G, Zhang Y et al (2021) Total laparoscopic transabdominal-transdiaphragmatic approach for treating Siewert II tumors: a prospective analysis of a case series. World J Surg Oncol 19(1):26CrossRefPubMedPubMedCentral
11.
go back to reference Kakeji Y, Yamamoto M, Ito S et al (2012) Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today 42(4):351–358CrossRefPubMed Kakeji Y, Yamamoto M, Ito S et al (2012) Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today 42(4):351–358CrossRefPubMed
12.
go back to reference Huang Y, Liu G, Wang X et al (2021) Safety and feasibility of total laparoscopic radical resection of Siewert type II gastroesophageal junction adenocarcinoma through the left diaphragm and left thoracic auxiliary hole. World J Surg Oncol 19(1):73CrossRefPubMedPubMedCentral Huang Y, Liu G, Wang X et al (2021) Safety and feasibility of total laparoscopic radical resection of Siewert type II gastroesophageal junction adenocarcinoma through the left diaphragm and left thoracic auxiliary hole. World J Surg Oncol 19(1):73CrossRefPubMedPubMedCentral
13.
go back to reference Wang W, Liu Z, Xiong W et al (2016) Totally laparoscopic spleen-preserving splenic hilum lymph nodes dissection in radical total gastrectomy: an omnibearing method. Surg Endosc 30(5):2030–2035CrossRefPubMed Wang W, Liu Z, Xiong W et al (2016) Totally laparoscopic spleen-preserving splenic hilum lymph nodes dissection in radical total gastrectomy: an omnibearing method. Surg Endosc 30(5):2030–2035CrossRefPubMed
14.
go back to reference Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP (2011) Oesophagogastric junction adenocarcinoma: which therapeutic approach. Lancet Oncol 12(3):296–305CrossRefPubMed Mariette C, Piessen G, Briez N, Gronnier C, Triboulet JP (2011) Oesophagogastric junction adenocarcinoma: which therapeutic approach. Lancet Oncol 12(3):296–305CrossRefPubMed
15.
go back to reference Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347(21):1662–1669CrossRefPubMed Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347(21):1662–1669CrossRefPubMed
16.
go back to reference Takiguchi S, Miyazaki Y, Shinno N et al (2016) Laparoscopic mediastinal dissection via an open left diaphragm approach for advanced Siewert type II adenocarcinoma. Surg Today 46(1):129–134CrossRefPubMed Takiguchi S, Miyazaki Y, Shinno N et al (2016) Laparoscopic mediastinal dissection via an open left diaphragm approach for advanced Siewert type II adenocarcinoma. Surg Today 46(1):129–134CrossRefPubMed
17.
go back to reference Goto H, Tokunaga M, Miki Y et al (2014) The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric Cancer 18(2):375–381CrossRefPubMedPubMedCentral Goto H, Tokunaga M, Miki Y et al (2014) The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric Cancer 18(2):375–381CrossRefPubMedPubMedCentral
18.
go back to reference Peng J, Wang WP, Yuan Y, Hu Y, Wang Y, Chen LQ (2015) Optimal extent of lymph node dissection for Siewert type II esophagogastric junction adenocarcinoma. Ann Thorac Surg 100(1):263–269CrossRefPubMed Peng J, Wang WP, Yuan Y, Hu Y, Wang Y, Chen LQ (2015) Optimal extent of lymph node dissection for Siewert type II esophagogastric junction adenocarcinoma. Ann Thorac Surg 100(1):263–269CrossRefPubMed
19.
go back to reference Yamashita H, Katai H, Morita S, Saka M, Taniguchi H, Fukagawa T (2011) Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg 254(2):274–280CrossRefPubMed Yamashita H, Katai H, Morita S, Saka M, Taniguchi H, Fukagawa T (2011) Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg 254(2):274–280CrossRefPubMed
20.
go back to reference Kurokawa Y, Hiki N, Yoshikawa T et al (2015) Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction. Surgery 157(3):551–555CrossRefPubMed Kurokawa Y, Hiki N, Yoshikawa T et al (2015) Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction. Surgery 157(3):551–555CrossRefPubMed
21.
go back to reference Wu XN, Liu CQ, Tian JY, Guo MF, Xu MQ (2017) Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma. Int J Surg 41:6–11CrossRefPubMed Wu XN, Liu CQ, Tian JY, Guo MF, Xu MQ (2017) Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma. Int J Surg 41:6–11CrossRefPubMed
22.
go back to reference Mariette C, Castel B, Balon JM, Van Seuningen I, Triboulet JP (2003) Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol 29(7):588–593CrossRefPubMed Mariette C, Castel B, Balon JM, Van Seuningen I, Triboulet JP (2003) Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol 29(7):588–593CrossRefPubMed
23.
go back to reference Barbour AP, Rizk NP, Gonen M et al (2007) Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246(1):1–8CrossRefPubMedPubMedCentral Barbour AP, Rizk NP, Gonen M et al (2007) Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg 246(1):1–8CrossRefPubMedPubMedCentral
24.
go back to reference Scheepers JJ, van der Peet DL, Veenhof AA, Cuesta MA (2009) Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route. Dis Esophagus 22(1):42–48CrossRefPubMed Scheepers JJ, van der Peet DL, Veenhof AA, Cuesta MA (2009) Influence of circumferential resection margin on prognosis in distal esophageal and gastroesophageal cancer approached through the transhiatal route. Dis Esophagus 22(1):42–48CrossRefPubMed
25.
go back to reference Gao F, Chen J, Wang T, Wang G, Zhang Z, Shen L (2014) Incidence of microscopically positive proximal margins in adenocarcinoma of the gastroesophageal junction. PLoS ONE 9(2):e88010CrossRefPubMedPubMedCentral Gao F, Chen J, Wang T, Wang G, Zhang Z, Shen L (2014) Incidence of microscopically positive proximal margins in adenocarcinoma of the gastroesophageal junction. PLoS ONE 9(2):e88010CrossRefPubMedPubMedCentral
26.
go back to reference Gertler R, Richter J, Stecher L, Nitsche U, Feith M (2016) What to do after R1-resection of adenocarcinomas of the esophagogastric junction. J Surg Oncol 114(4):428–433CrossRefPubMed Gertler R, Richter J, Stecher L, Nitsche U, Feith M (2016) What to do after R1-resection of adenocarcinomas of the esophagogastric junction. J Surg Oncol 114(4):428–433CrossRefPubMed
27.
go back to reference Papachristou DN, Agnanti ND, Agostino H, Fortner JG (1980) Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg 139(5):711–713CrossRefPubMed Papachristou DN, Agnanti ND, Agostino H, Fortner JG (1980) Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg 139(5):711–713CrossRefPubMed
28.
go back to reference Mattioli S, Di Simone MP, Ferruzzi L et al (2001) Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus 14(2):104–109CrossRefPubMed Mattioli S, Di Simone MP, Ferruzzi L et al (2001) Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus 14(2):104–109CrossRefPubMed
29.
go back to reference Tsujitani S, Okuyama T, Orita H et al (1995) Margins of resection of the esophagus for gastric cancer with esophageal invasion. Hepatogastroenterology 42(6):873–877PubMed Tsujitani S, Okuyama T, Orita H et al (1995) Margins of resection of the esophagus for gastric cancer with esophageal invasion. Hepatogastroenterology 42(6):873–877PubMed
Metadata
Title
Transthoracic single-port-assisted laparoscopic gastrectomy versus laparoscopic transhiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction: a single-center retrospective study
Authors
Jin Li
Wenjun Xiong
Huahui Ou
Tingting Yang
Shuihua Jiang
Haipeng Huang
Yansheng Zheng
Lijie Luo
Xiaofeng Peng
Wei Wang
Publication date
21-02-2024
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 4/2024
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-024-10680-7

Other articles of this Issue 4/2024

Surgical Endoscopy 4/2024 Go to the issue